Show simple item record

dc.contributor.authorBrissova, Marcela
dc.contributor.authorBlodgett, David
dc.contributor.authorGreiner, Dale L.
dc.contributor.authorHarlan, David M.
dc.contributor.authorPowers, Alvin C.
dc.date2022-08-11T08:09:49.000
dc.date.accessioned2022-08-23T16:45:00Z
dc.date.available2022-08-23T16:45:00Z
dc.date.issued2018-03-06
dc.date.submitted2018-05-30
dc.identifier.citation<p>Cell Rep. 2018 Mar 6;22(10):2667-2676. doi: 10.1016/j.celrep.2018.02.032. <a href="https://doi.org/10.1016/j.celrep.2018.02.032">Link to article on publisher's site</a></p>
dc.identifier.issn2211-1247 (Electronic)
dc.identifier.doi10.1016/j.celrep.2018.02.032
dc.identifier.pmid29514095
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40610
dc.description<p>Full author list omitted for brevity. For the full list of authors, see article.</p>
dc.description.abstractMany patients with type 1 diabetes (T1D) have residual beta cells producing small amounts of C-peptide long after disease onset but develop an inadequate glucagon response to hypoglycemia following T1D diagnosis. The features of these residual beta cells and alpha cells in the islet endocrine compartment are largely unknown, due to the difficulty of comprehensive investigation. By studying the T1D pancreas and isolated islets, we show that remnant beta cells appeared to maintain several aspects of regulated insulin secretion. However, the function of T1D alpha cells was markedly reduced, and these cells had alterations in transcription factors constituting alpha and beta cell identity. In the native pancreas and after placing the T1D islets into a non-autoimmune, normoglycemic in vivo environment, there was no evidence of alpha-to-beta cell conversion. These results suggest an explanation for the disordered T1D counterregulatory glucagon response to hypoglycemia.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=29514095&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rights© 2018 The Authors. Under a Creative Commons license: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectalpha cells
dc.subjectglucagon
dc.subjecthuman
dc.subjectinsulin
dc.subjectpancreatic islet
dc.subjecttype 1 diabetes
dc.subjectCell Biology
dc.subjectCellular and Molecular Physiology
dc.subjectEndocrine System Diseases
dc.subjectEndocrinology
dc.subjectGenetic Phenomena
dc.subjectHormones, Hormone Substitutes, and Hormone Antagonists
dc.subjectImmune System Diseases
dc.subjectNutritional and Metabolic Diseases
dc.titlealpha Cell Function and Gene Expression Are Compromised in Type 1 Diabetes
dc.typeJournal Article
dc.source.journaltitleCell reports
dc.source.volume22
dc.source.issue10
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=4424&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/3413
dc.identifier.contextkey12222298
refterms.dateFOA2022-08-23T16:45:01Z
html.description.abstract<p>Many patients with type 1 diabetes (T1D) have residual beta cells producing small amounts of C-peptide long after disease onset but develop an inadequate glucagon response to hypoglycemia following T1D diagnosis. The features of these residual beta cells and alpha cells in the islet endocrine compartment are largely unknown, due to the difficulty of comprehensive investigation. By studying the T1D pancreas and isolated islets, we show that remnant beta cells appeared to maintain several aspects of regulated insulin secretion. However, the function of T1D alpha cells was markedly reduced, and these cells had alterations in transcription factors constituting alpha and beta cell identity. In the native pancreas and after placing the T1D islets into a non-autoimmune, normoglycemic in vivo environment, there was no evidence of alpha-to-beta cell conversion. These results suggest an explanation for the disordered T1D counterregulatory glucagon response to hypoglycemia.</p>
dc.identifier.submissionpathoapubs/3413
dc.contributor.departmentDepartment of Medicine, Diabetes Division, Diabetes Center of Excellence
dc.source.pages2667-2676


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
1_s2.0_S2211124718302134_main.pdf
Size:
4.473Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

© 2018 The Authors. Under a Creative Commons license: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Except where otherwise noted, this item's license is described as © 2018 The Authors. Under a Creative Commons license: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)